Kenneth Lee, MD
Neurological Surgery · Greenville, NCNPI 1619079571
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $8,519 of the $12,080 with a category attached, or 70.5%. GT Medical Technologies, Inc accounts for 71.5% of it on its own, with 18 other manufacturers making up the rest. Reporting peaked in 2023 at $5,365 and has fallen 90.2% since, to $525 in 2025.
Across 58 payments — averaging $208.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GT Medical Technologies, Inc$9K
- Novocure Inc.$3K
- Arbor Pharmaceuticals, Inc.$161
- Medtronic$112
- Abbott$96
- Si-bone, Inc.$88
- plus $483 from 13 others
Across 54 payments — averaging $2720.10 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- GT Medical Technologies, Inc$68K
- Mitsubishi Tanabe Pharma Development America, Inc.$25K
- Biogen$23K
- Arbor Pharmaceuticals, Inc.$11K
- Novocure Inc.$10K
- Tanabe Pharma America, Inc.$5K
- plus $5K from 1 others
What the payments were for
- Consulting fees$2,00017%
- Speaking & faculty fees$8,51971%
- Food & beverage$1,53913%
- Education$220%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GT Medical Technologies, Inc | 11 | $8,640 |
| Novocure Inc. | 1 | $2,500 |
| Arbor Pharmaceuticals, Inc. | 16 | $161 |
| Medtronic(2 entities) | 4 | $112 |
| Abbott | 1 | $96 |
| Si-bone, Inc. | 3 | $88 |
| Baxter Healthcare | 4 | $79 |
| Johnson & Johnson | 3 | $77 |
| AstraZeneca(2 entities) | 3 | $62 |
| Stryker | 1 | $54 |
| CTL Medical Corporation | 1 | $40 |
| Orthofix Medical, Inc. | 2 | $33 |
| Zimvie Inc. | 1 | $31 |
| CSL Behring | 2 | $31 |
| Irras USA, Inc. | 1 | $19 |
| Kerecis Limited | 1 | $18 |
| Stimwave Technologies Incorporated | 1 | $15 |
| Boston Scientific | 1 | $13 |
| Longeviti Neuro Solutions Inc | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$12,080 in reported general payments places this provider in the 60th percentile of 196 neurological surgery providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dexamethasone | 47 | $1,103 |
| Methylprednisolone | 23 | $157 |
Paid to pharmacies, not to this prescriber.
Other neurological surgery in Greenville
- Richard DalyaiGreenville$49K
- Robert IsaacsDurham$6.6M
- Christopher ShaffreyDurham$4.5M
- Domagoj CoricCharlotte$2.3M
- John ThomasWilmington$1.8M
- Alexander PowersKernersville$1.7M
- Charles BranchAdvance$1.6M
- Paul KimCharlotte$1.5M
- William HunterGastonia$1.3M
- Kevin CahillSupply$1.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.